TherapeuticsMD (TXMD) Asset Utilization Ratio (2011 - 2026)
TherapeuticsMD's (TXMD) quarterly Asset Utilization Ratio came in at 0.09 in Q1 2026, up 86.54% YoY from 0.05 in Q1 2025, and up 12.56% on a QoQ basis from 0.08 in Q4 2025.
TherapeuticsMD (TXMD) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 15 years of Asset Utilization Ratio data on file, last reported at 0.09 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 86.54% year-over-year to 0.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09 (up 86.54% YoY) and the FY2025 annual result came in at 0.08, up 84.29% from the prior year.
- Asset Utilization Ratio grew to 0.09 in Q1 2026, from 0.08 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.33 in Q3 2023 to a low of 0.03 in Q2 2024.
- A 5-year average of 0.33 and a median of 0.08 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio surged 830.44% — and 2024, when it tumbled 97.89%.
- Tracing TXMD's Asset Utilization Ratio over 5 years: stood at 0.62 in 2022, then sank by 95.3% to 0.03 in 2023, then soared by 53.28% to 0.04 in 2024, then soared by 76.21% to 0.08 in 2025, then rose by 12.56% to 0.09 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.09 (Q1 2026), 0.08 (Q4 2025), and 0.07 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | 0.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.09 |
| Mar 31, 2026 | 0.09 |
| Dec 31, 2025 | 0.08 |
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.07 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.03 |
| Dec 31, 2023 | 0.03 |
| Sep 30, 2023 | 1.33 |
| Jun 30, 2023 | 1.23 |
| Mar 31, 2023 | 0.93 |
| Dec 31, 2022 | 0.62 |
| Sep 30, 2022 | 0.14 |
| Jun 30, 2022 | 0.32 |
| Mar 31, 2022 | 0.45 |
| Dec 31, 2021 | 0.46 |
| Sep 30, 2021 | 0.43 |